Syndrome  >>  otamixaban (XRP0673)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
otamixaban (XRP0673) / Sanofi
SEPIA-ACS1, NCT00317395 / 2006-000506-22: Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome

Checkmark ACC 2013: SEPIA- ACS1 TIMI
Mar 2013 - Mar 2013: ACC 2013: SEPIA- ACS1 TIMI
Completed
2
3241
US, Canada, Europe, RoW
Otamixaban (XRP0673), unfractionated heparin, eptifibatide
Sanofi
Coronary Disease
10/08
03/09

Download Options